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Noninvasive Assessment of Coronary Artery Disease
Anatomy, Physiology, and Clinical Outcome*
Paul Schoenhagen, MD,† Eike Nagel, MD, PHD‡
Cleveland, Ohio; and London, United KingdomIn this issue of iJACC, Hamdan et al. (1) compare
noninvasive coronary angiography with a state-of-
the-art magnetic resonance system (3.0-T, 32-
channel) and a standard 64-slice computed tomog-
raphy (CT) scanner in 120 patients with stable or
suspected coronary artery disease. In a selected
patient population (excluding patients with acute
coronary syndromes, advanced heart failure, stents,
bypass surgery, arrhythmia, body mass index 40
kg/m2) 95% and 97% of segments could be ade-
quately visualized with magnetic resonance angiog-
See page 50
raphy (MRA) and CT, respectively. Compared
with invasive coronary angiography, the data dem-
onstrate comparable diagnostic accuracy of the non-
invasive modalities, with a slight advantage of CT
(significant for the left circumflex artery).
The anatomic reference standard in this compar-
ison is invasive coronary angiography. Invasive an-
giography allows precise description of coronary
luminal stenosis as the basis for planning coronary
revascularization and is relatively safe; and its inva-
siveness allows access for potential transcatheter
revascularization (percutaneous coronary interven-
tion). Therefore, at this time it remains the imaging
modality of choice for symptomatic, high-risk pa-
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
From the †Cleveland Clinic, Cardiovascular Imaging, Cleveland, Ohio;
and ‡King’s College, London BHF Centre of Research Excellence,
NIHR Biomedical Research Centre, Guy’s and St. Thomas Hospital
Trust, Division of Imaging Sciences, The Rayne Institute, St. Thomas’
Hospital, London, United Kingdom. Dr. Schoenhagen has reported that
he has no relationships to disclose. Dr. Nagel has received significant
grant support from Philips Healthcare and Bayer Schering Pharma.tients. However, invasive angiography has 2 signif-
icant limitations.
First, the correlation between anatomic stenosis
severity and physiologic, hemodynamic significance
is only modest (2). In the catheterization laboratory,
this limitation can be overcome by the combination
of angiography with fractional flow reserve, which
allows reliable assessment of lesion significance and
improves planning of revascularization (3).
Second, invasive angiography is limited in the
evaluation of the disease process in the vessel wall,
including plaque burden and vulnerable plaque (4).
These 2 limitations reduce the ability of invasive
angiography to predict future cardiovascular events,
particularly in intermediate risk populations. This
has important clinical implications, because recent
clinical studies demonstrate that deferring percuta-
neous coronary intervention on the basis of frac-
tional flow reserve or lesion location, combined
with optimal medical management, improved or at
least did not negatively impact clinical outcome
including mortality (3,5).
These results demonstrate that assessing coro-
nary artery disease is complex and requires evalua-
tion of anatomy, physiology, and eventually clinical
end points. This also holds true for noninvasive
coronary assessment with magnetic resonance im-
aging (MRI) and CT. Noninvasive coronary an-
giography is challenging, because of the small vessel
size and rapid motion during the cardiac cycle.
Therefore, in general, temporal resolution, spatial
resolution, and diagnostic accuracy for anatomic
assessment of luminal stenosis are lower than with
invasive angiography. In recent years, MRA has
suffered more from these challenges than computed
tomography angiography (CTA), resulting in lower
overall accuracy of MRA versus CT. However, in
addition to the assessment of luminal stenosis,
noninvasive imaging provides additional prognostic
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63nformation, which allows decisions about optimal
edical management.
After proof-of-concept and smaller clinical
rials, the first multicenter coronary MRA trial
as published in 2001 (6). It used targeted vol-
me acquisitions of individual coronary arteries
3-dimensional spoiled gradient-echo sequence),
hich allowed visualization of 84% of segments.
ince then, coronary MRA has advanced signifi-
antly with significantly improved accuracy versus
nvasive angiography. Importantly, the main differ-
nce of accuracy between MRA and CTA is the
igher positive predictive value of CT rather than
he negative predictive value, with very small dif-
erences in patients with low pre-test probability
7). Further improvements are achieved with combin-
ng 32-channel technology, higher field strengths
3.0-T), and receive-transmit systems to optimize the
ignal-to-noise ratio (SNR) and minimize artifacts, as
escribed in the current report (1).
The main strength of MRI, however, is its ability
o provide additional, comprehensive physiological/
unctional assessment of coronary artery disease,
ncluding stress perfusion (8). Previous studies us-
ng stress perfusion demonstrate that absence of
schemia portends good prognosis (9). In contrast,
RA is limited in the assessment of coronary
laque.
The first multicenter CTA trial was published in
006 (10). With 16-detector technology, only 71%
f segments were evaluable, but subsequent 64-slice
ulti-center trials showed improved results. Al-
hough 64-slice CT is currently considered the
linical standard, state-of-the-art results are de-
cribed with more advanced CT systems, including
ide z-coverage (volume) scanners and dual source
echnology (11,12). The historically high radiation
xposure has been significantly decreased with pro-
pective triggering, reduced tube voltage, and iter-fractional flow reserve in patients with moderate lipid-lowA strength of CT is the additional assessment of
alcified (“calcium scoring”) and noncalcified plaque
urden. Recent studies demonstrate its diagnostic
alue for future cardiovascular events (15). Al-
hough recent CT studies describe the potential for
tress perfusion imaging (16), clinical assessment of
hysiology is currently limited with CT.
Reflecting these data, current guidelines recom-
end invasive coronary imaging in high-risk pa-
ient populations. Noninvasive coronary imaging is
ecommended in certain intermediate risk popula-
ions, in particular if functional tests are not feasi-
le. In lower pre-test populations, techniques with
igh negative predictive value are most appropriate.
lthough this has been mainly interpreted as using
alcium Scoring or CTA, MRA might also play a
ole, especially if the assessment of vessel wall
lterations becomes more readily available.
In summary, both MRA and CT can assess the
natomy of coronary artery stenoses, with high
egative predictive value. Comparing diagnostic
ccuracy of CT and MRI for anatomic coronary
ssessment as described in the report by Hamdan
1) is important. However, to fully understand the
alue of these noninvasive modalities in the assess-
ent of coronary artery disease, their additional
rognostic value needs to be considered. In the case
f MRA and CT, this is focused on physiology and
plaque) anatomy, respectively. Future prospective
tudies will assess the value of these modalities in a
ore comprehensive fashion against clinical outcome.
uch clinical trials are currently enrolling patients
17–19). Over the next several years, such data will
efine the role of these modalities in the context of
xisting invasive and noninvasive modalities.
eprint requests and correspondence: Dr. Paul Schoenha-
en, Imaging Institute and Heart and Vascular Institute,
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